The Quantellect read.As of Nov 19, 2026, 4 active firms cover Ocugen Inc: 4 rate it Buy or better, 0 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets span $7.00 to $11.00, a moderate spread. The average target of $9.38 sits 1170% above the current $0.74. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.07 next quarter toward $-0.18 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 active firms
Buy
Strong Buy00%
Buy4100%
Neutral00%
Sell00%
Strong Sell00%
Based on 4 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$9.38
+1169.6% upside
Average target across 4 active firms as of Nov 19, 2026 vs $0.74 current
Highest Target$11.00
Average Target$9.38
Lowest Target$7.00
Detailed analyst forecasts for OCGN
Showing 1–4 of 4 named analysts shown · 4 active firms in the rating projection
As of Nov 19, 2026, 4 of 4 active firms rate OCGN a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
OCGN EPS & revenue forecast
EPS · NEXT QUARTER
$-0.07
Range $-0.08 – $-0.06 · 3 analysts · +17% YoY
Next period, 3 analysts expect Ocugen Inc to earn $-0.07 a share (range $-0.08 – $-0.06), versus $-0.06 a year earlier. Full-year consensus is $-0.20, growing to $-0.18 the year after.
REVENUE · NEXT QUARTER
$1.1M
Range $1.0M – $1.2M · 3 analysts · -28% YoY
Revenue is expected to reach $1.1M (range $1.0M – $1.2M), -28.2% year-over-year. Full-year consensus is $6.0M, rising to $7.3M next year.
Top analysts covering Ocugen Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on OCGN.
#1
Daniil Gataulin
Chardan Capital · Rank #51
Buy
$7.00+848.0% to target
Overall win rate
52%
+ Follow
#2
Swayampakula Ramakanth
HC Wainwright & Co. · Rank #321
Buy
$9.50+1186.6% to target
Overall win rate
38%
+ Follow
#3
WI
Whitney Ijem
Canaccord Genuity · Rank #392
Buy
$11.00+1389.7% to target
Overall win rate
35%
+ Follow
#4
Leland Gershell
Oppenheimer · Rank #404
Buy
$10.00+1254.3% to target
Overall win rate
35%
+ Follow
#5
RL
Robert LeBoyer
Noble Financial
Buy
$12.00+1525.1% to target
Coverage
—
+ Follow
OCGN stock forecast FAQ
What is OCGN's average 12-month price target?+
The 4 active firms with a live target average $9.38 for Ocugen Inc over the next 12 months, ranging from a $11.00 high to a $7.00 low, as of Nov 19, 2026.
Is OCGN stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 4 active firms as of Nov 19, 2026, 4 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for OCGN?+
The Street-high target is $11.00 (Canaccord Genuity), and the Street-low is $7.00 (Chardan Capital). The average of all 4 active-firm targets is $9.38.
How many active Wall Street firms cover OCGN?+
4 active firms have a recognized rating on Ocugen Inc as of Nov 19, 2026, and 4 active firms carry a live 12-month price target.
Who is the most accurate analyst covering OCGN?+
Among analysts who currently cover OCGN, Daniil Gataulin of Chardan Capital has the strongest overall Quantellect track record (Rank #51). Their current call is Buy with a $7.00 target.
What is Ocugen Inc's projected EPS for next quarter?+
The consensus estimate is $-0.07 per share (range $-0.08 – $-0.06) across 3 analysts. Full-year EPS is projected at $-0.20, rising to $-0.18 the following year.
How much revenue is Ocugen Inc expected to report next quarter?+
Consensus revenue is $1.1M (range $1.0M – $1.2M). Full-year revenue is projected at $6.0M, growing to $7.3M next year.
Have analysts been upgrading or downgrading OCGN lately?+
As of Nov 19, 2026, 4 of 4 active firms rate OCGN a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their OCGN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.